These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8742965)

  • 21. Hepatic hepatitis C virus RNA in chronic hepatitis C.
    Craxì A; Di Marco V; Almasio PL
    Ann Intern Med; 1996 Jan; 124(1 Pt 1):72. PubMed ID: 7503483
    [No Abstract]   [Full Text] [Related]  

  • 22. Is it now the time to update treatment protocols for lymphomas with new anti-virus systems?
    Luppi M; Barozzi P; Potenza L; Riva G; Morselli M; Torelli G
    Leukemia; 2004 Oct; 18(10):1572-5. PubMed ID: 15284857
    [No Abstract]   [Full Text] [Related]  

  • 23. Cryoglobulinaemia, hepatitis C and interferon therapy.
    Careless D; Sandford N; Tinniswood R; Cobcroft R; Boyle R; Gill D; Hogan P
    Aust N Z J Med; 1993 Aug; 23(4):414-5. PubMed ID: 8240162
    [No Abstract]   [Full Text] [Related]  

  • 24. Extrahepatic manifestations of chronic viral hepatitis.
    Willson RA
    Am J Gastroenterol; 1997 Jan; 92(1):3-17. PubMed ID: 8995930
    [No Abstract]   [Full Text] [Related]  

  • 25. Interferon for hepatitis C.
    Puoti C; Magrini A; Stati T; Rossi P; Montagnese F; Resta S
    Lancet; 1997 Feb; 349(9049):398-9. PubMed ID: 9033470
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of acute hepatitis C in a child with thalassemia major using weight-based peginterferon alpha-2b.
    Sharara AI; Aoun E; Koussa S; Inati A; Taher A
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1221. PubMed ID: 16824084
    [No Abstract]   [Full Text] [Related]  

  • 27. [Epidermolysis bullosa acquisita and hepatitis C].
    Thiery S; Misery L; Chossegros P; Kanitakis J; Ghohestani R; Forestier JY; Trepo C; Faure M; Claudy A
    Ann Dermatol Venereol; 1998 Apr; 125(4):264-7. PubMed ID: 9747265
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is interferon alpha 2b effective on cryoglobulinaemia related to hepatitis C virus?
    Taillan B; Ferrari E; Pesce A; Garnier G; Vinti H; Fuzibet JG; Dujardin P
    Clin Rheumatol; 1992 Dec; 11(4):579. PubMed ID: 1486757
    [No Abstract]   [Full Text] [Related]  

  • 29. [Mixed cryoglobulinemia associated with hepatitis C virus. Value of interferon].
    Durand JM; Kaplanski G; Lefevre P; Soubeyrand J
    Presse Med; 1992 Jan; 21(2):87. PubMed ID: 1531534
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of human leukocyte alpha interferon on cryoglobulinaemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection.
    Gilli P; Stabellini N; Storari A; Gualandi G; Guerra G; Ghinelli F
    Nephrol Dial Transplant; 1996 Mar; 11(3):526-8. PubMed ID: 8671825
    [No Abstract]   [Full Text] [Related]  

  • 31. Successful pegylated interferon alpha2a monotherapy for hepatitis C virus infection in a transplanted patient who relapsed after the preceding course.
    Ichikawa T; Taura N; Miyaaki H; Matsuzaki M; Eguchi S; Takatsuki M; Kanematsu T; Nakao K
    Transpl Infect Dis; 2011 Aug; 13(4):438-40. PubMed ID: 21309967
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hepatitis C infection with false negative serology in a patient with mixed cryoglobulinemic vasculitis].
    Tini GM; Wüscher V; Jeker R
    Dtsch Med Wochenschr; 2007 Mar; 132(12):616-8. PubMed ID: 17357905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Extrahepatic manifestations of hepatitis C virus].
    Tohme A; Haddad F; Malek N; Ghayad E
    J Med Liban; 1998; 46(2):84-8. PubMed ID: 10095833
    [No Abstract]   [Full Text] [Related]  

  • 34. [Lower limb ischaemia in a patient with HCV hepatitis treated with alpha-interferon. Brouer classification type III cryoglobulinemia].
    García García B; Sancho Bueso T; Gil Catalinas F; Bernardino de la Serna JI; García Puig J
    Rev Clin Esp; 2001 May; 201(5):283-4. PubMed ID: 11458802
    [No Abstract]   [Full Text] [Related]  

  • 35. [Hepatitis C virus genotype 4: epidemiology and treatment].
    Castera L; Morice Y; Grando V; Bon C; Dény P; Roulot D
    Gastroenterol Clin Biol; 2003 Jun; 27(6-7):596-604. PubMed ID: 12910223
    [No Abstract]   [Full Text] [Related]  

  • 36. Association between persistent lymphatic infection by hepatitis C virus after antiviral treatment and mixed cryoglobulinemia.
    Giannini C; Petrarca A; Monti M; Arena U; Caini P; Solazzo V; Gragnani L; Milani S; Laffi G; Zignego AL
    Blood; 2008 Mar; 111(5):2943-5. PubMed ID: 18299456
    [No Abstract]   [Full Text] [Related]  

  • 37. Pegylated interferon alpha-2b in patients with acute hepatitis C.
    Mukhopadhyay A
    Natl Med J India; 2006; 19(4):201-2. PubMed ID: 17100108
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of hepatocellular carcinoma after clearance of hepatitis C virus with interferon therapy.
    Tong MJ; Lai LP; Murakami-Mori K
    West J Med; 1997 Aug; 167(2):103-5. PubMed ID: 9291751
    [No Abstract]   [Full Text] [Related]  

  • 39. Mixed cryoglobulinemia: new concepts.
    Ramos-Casals M; Trejo O; García-Carrasco M; Cervera R; Font J
    Lupus; 2000; 9(2):83-91. PubMed ID: 10787003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cryoglobulinemia in hepatitis C virus chronic active hepatitis: effects of interferon-alpha therapy.
    Casaril M; Capra F; Gabrielli GB; Bassi A; Squarzoni S; Dagradi R; De Maria E; Corrocher R
    J Interferon Cytokine Res; 1996 Aug; 16(8):585-8. PubMed ID: 8877728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.